Choledocholithiasis with Drs. David Vitale & Lucas Neff
Inside this episode
Kai, the Library's AI content creator,
listened to this episode and mapped who's speaking, the chapters,
key claims, and cases. Every item links to the exact moment in the
recording.
AI-enriched
Inside this episode
Who's speaking
- Cecilia Gigena — host
- David Vitale — guest
- Luke Neff — guest
- Speaker 4
Chapters
- 0:00Introduction and Risk Stratification — Introduction of speakers and discussion of choledocholithiasis risk factors, including metabolic diseases, hemolysis, and biliary anomalies. Presentation of a case of a 14-year-old with right upper quadrant pain and discussion of ASGE risk stratification guidelines.
- 2:38Pediatric Predictors and Treatment Approaches — Discussion of pediatric-specific predictors for common bile duct stones, including the pediatric duct score. Comparison of ERCP versus laparoscopic common bile duct exploration, with emphasis on institutional expertise and resource availability.
- 5:17Surgery-First Paradigm — Dr. Neff presents a surgery-first approach using intraoperative cholangiogram (IOC) to avoid longer hospital stays and reduce resource utilization. Discussion of techniques for laparoscopic stone removal, including flushing stones forward into the duodenum and ampullary dilation.
- 9:37Technical Details of Laparoscopic CBD Exploration — Detailed description of equipment and technique for laparoscopic common bile duct exploration, including use of ureteral stents, guide wires, and angioplasty balloons. Discussion of balloon sizing, dilation technique, and when to abort the procedure.
- 13:47Learning Curve and Summary — Discussion of the learning curve (5-10 cases) for laparoscopic common bile duct exploration and summary of key diagnostic and treatment principles.
Key claims
- 1:03Choledocholithiasis is more common in older children, children with higher BMI, and patients of Hispanic ethnicity — David Vitale
- 0:55Risk factors for choledocholithiasis include metabolic diseases, hemolysis such as sickle cell, and congenital biliary anomalies like choledochal cysts — David Vitale
- 1:52According to ASGE guidelines, patients with high probability of common bile duct stones (common bile duct stones seen on ultrasound, ascending cholangitis, or quite high bilirubin) should go straight to ERCP — David Vitale
- 2:11Patients with intermediate risk (abnormal liver biochemical tests or dilated common bile ducts) can undergo endoscopic ultrasound, MRCP, laparoscopic cholangiogram, or intraoperative ultrasound — Cecilia Gigena
- 2:40In pediatric patients, direct bilirubin or conjugated bilirubin more than 2 was the most predictive factor for common bile duct stones — David Vitale
- 2:50Common bile duct diameter greater than 6 millimeters was most sensitive for predicting common bile duct stones in children, although without statistical significance — Cecilia Gigena
- 3:03The pediatric duct score (published in Journal of American College of Surgeons with 10 centers) found that ducts greater than 6 millimeters, common bile duct stones on ultrasound, or total bilirubin greater than 1.8 were the most predictive risk factors — David Vitale
- 3:41Pediatric literature with small sample size shows that doing same anesthesia laparoscopic cholecystectomy with ERCP in stone disease led to less anesthesia time and lower length of stay — David Vitale
- 4:03Retrospective data comparing ERCP versus laparoscopic common bile duct exploration is conflicted and the choice is probably institution and provider dependent based on expertise — David Vitale
- 4:18Randomized trials from 2013 show no significant difference in morbidity, mortality, retained stones, or failure rates between ERCP and laparoscopic common bile duct exploration — Cecilia Gigena
- 4:39Stones above the cystic duct pose a problem because they can float up during attempted laparoscopic removal, making the procedure more difficult — David Vitale
- 5:00Local expertise and availability is probably the most important factor in deciding between ERCP and laparoscopic common bile duct exploration — David Vitale
- 9:12Most free-standing children's hospitals do not have ERCP capabilities — Cecilia Gigena
- 6:42The mantra for laparoscopic common bile duct exploration is all stones go forward, using balloons to dilate the sphincter and flush stones antegrade into the duodenum — Luke Neff
- 7:30If you're having to open up the common bile duct to extract the stone and you had ERCP capability, that's probably not the right thing to do in most cases — Luke Neff
- 9:37A 12 gauge angiocath is used for laparoscopic common bile duct exploration, with a new incision made to achieve a flat angle of entry into the cystic ductotomy — Luke Neff
- 9:57A 6 French ureteral stent cut down shorter for better flow is used with a glide wire, employing a cylinder technique to navigate the valves — Luke Neff
- 10:37An angioplasty balloon of 6 or 8 millimeters (but definitely not more than that) is used to dilate the sphincter — Luke Neff
- 11:02The balloon is inflated in the duct and pulled back to provide tactile feedback to locate the sphincter, then partially deflated to straddle the ampulla, then inflated to full profile under fluoroscopy and held for about 5 minutes — Luke Neff
- 11:23Never use a balloon larger than the dilated common bile duct because literature shows a higher rate of pancreatitis with ampullary dilation without sphincterotomy — David Vitale
- 12:24If the pancreatic duct is seen on fluoroscopy during the procedure, stop because that has a higher risk for pancreatitis — Cecilia Gigena
- 12:34The prevalence of stone disease is increasing — Luke Neff
- 13:40The learning curve for laparoscopic common bile duct exploration is around 5 to 10 cases, though this is person-specific — Luke Neff
- 13:24The position of the 12-gauge angiocath is really important, and the ability to manipulate the catheter and wire in the duct depends on the initial setup and how flat the angle of entry is into the cystic duct — Luke Neff
Cases discussed
- 1:1714-year-old female with choledocholithiasis
Open questions
- What is the optimal balloon size for ampullary dilation in pediatric patients of different ages and common bile duct diameters?
- How can centers without pediatric ERCP capabilities develop competency in laparoscopic common bile duct exploration?
- What are the long-term outcomes comparing ERCP versus laparoscopic exploration in pediatric choledocholithiasis?
Topic overview
This discussion covers the diagnosis and management of choledocholithiasis (common bile duct stones) in pediatric patients. The speakers compare two treatment approaches: ERCP (endoscopic retrograde cholangiopancreatography) versus laparoscopic common bile duct exploration. Key clinical predictors for common bile duct stones in children include direct bilirubin greater than 2 mg/dL, common bile duct diameter greater than 6 millimeters, and total bilirubin greater than 1.8 mg/dL. The discussion emphasizes that both ERCP and laparoscopic exploration have similar outcomes in expert hands, but resource availability and institutional expertise should guide the choice of approach.
Key takeaways
- Direct bilirubin >2 mg/dL and CBD diameter >6mm are most predictive of choledocholithiasis in children requiring intervention.
- Same-anesthesia ERCP with laparoscopic cholecystectomy reduces total anesthesia time and hospital length of stay versus staged procedures.
- Intraoperative cholangiogram allows real-time decision-making: negative IOC permits immediate discharge; positive IOC guides CBD exploration or ERCP.
- Local expertise availability should drive treatment approach—ERCP versus laparoscopic CBD exploration show equivalent outcomes in retrospective data.
- Stones above the cystic duct junction pose technical challenges for laparoscopic removal and may require endoscopic intervention.
Keywords
Hashtags
Transcript
Click "Show Transcript" to view the full text (15128 characters)
Comments